BDBM23296 (2S,5R,7S,9R,14R,15R,16S)-14-[(1R)-4-({2-[(7-chloroquinolin-4-yl)amino]ethyl}amino)-1-methylbutyl]-5,9-bis(acetyloxy)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-16-yl acetate::4-amino-7-chloroquinoline (ACQ)-based compound, 1::JMC514388 Compound 6
SMILES [H][C@@]12C[C@@H](CC[C@]1(C)C1C[C@H](OC(C)=O)[C@]3(C)[C@H](CCC3C1[C@@H](C2)OC(C)=O)[C@H](C)CCCNCCNc1ccnc2cc(Cl)ccc12)OC(C)=O
InChI Key InChIKey=OIIVAUPRMHYHRI-GLYQTUQUSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 23296
Affinity DataIC50: 1.00E+4nMpH: 7.3 T: 2°CAssay Description:Botox A catalyzed the hydrolysis of substrate peptide between residues 11 (glutamine) and 12 (arginine), corresponding to residues 197 and 198 of SNA...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMpH: 7.3 T: 2°CAssay Description:Botox A catalyzed the hydrolysis of substrate peptide between residues 11 (glutamine) and 12 (arginine), corresponding to residues 197 and 198 of SNA...More data for this Ligand-Target Pair